Mebeverine
- Generic Name
- Mebeverine
- Drug Type
- Small Molecule
- Chemical Formula
- C25H35NO5
- CAS Number
- 3625-06-7
- Unique Ingredient Identifier
- 7F80CC3NNV
Overview
Mebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms.
Background
Mebeverine has been investigated for the treatment of Irritable Bowel Syndrome and Post-cholecystectomy Gastrointestinal Spasms.
Indication
治疗由肠易激综合症（IBS）引起的腹痛痉挛，肠功能紊乱和肠部不适，治疗由于器质性疾病继发引起的肠痉挛。
Associated Conditions
- Abdominal Pain
- Abdominal Spasms
- Abnormal Bowel Movement Such as Constipation, Diarrhea, Abdominal Pain
- Irritable Bowel Syndrome (IBS)
- Bowel discomfort
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
DUSPATALIN RETARD CAPSULE 200 mg
Manufacturer:ABBOTT BIOLOGICALS B.V., Mylan Laboratories SAS
Form:CAPSULE
Strength:200 mg
Online:Yes
Approved: 1994/03/10
Approval:SIN07666P
MEBETIN TABLET 135 mg
Manufacturer:SAM CHUN DANG PHARM CO LTD
Form:TABLET, SUGAR COATED
Strength:135 mg
Online:Yes
Approved: 1998/07/09
Approval:SIN09873P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath